Israel Englander Viatris Inc Call Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $502,500 - $601,000	-50,000 Reduced 20.0%	200,000 $2.13 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $2.82 Million - $3.38 Million	250,000 New	250,000 $2.99 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $4 Million - $5.34 Million	-435,300 Reduced 88.6%	56,000 $539,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $3.22 Million - $4.26 Million	368,800 Added 301.06%	491,300 $5.47 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $14,416 - $18,921	-1,700 Reduced 1.37%	122,500 $1.04 Million

1,100

969M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.